Difference between revisions of "Liu L, et al. PLoS ONE (2013) cited as Ref 392 in DOI: 10.1038/s41392-020-0110-5 (Q9655)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 8, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Inhibition of oxidative stress-elicited AKT activation facilitates PPARgamma agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cells, #quickstatements; #temporary_batch_1...) |
||
Property / title | |||
+ | Inhibition of oxidative stress-elicited AKT activation facilitates PPARgamma agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cells (English) | ||
Property / title: Inhibition of oxidative stress-elicited AKT activation facilitates PPARgamma agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cells (English) / rank | |||
+ | Normal rank |
Revision as of 22:01, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Liu L, et al. PLoS ONE (2013) cited as Ref 392 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Liu L
0 references
2013
0 references
PLoS ONE
0 references
8
0 references
Inhibition of oxidative stress-elicited AKT activation facilitates PPARgamma agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cells (English)
0 references